D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
FLNA holding history
Filana Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FLNA overviewAll 13F holders of FLNAFull Q2 2026 holdings
- Shares (Q2 2026)
- 485,025
- Value
- $577.2K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 485,025 | $577.2K | <0.1% | −74,180−13.3% | Reduced | Holders |
| Q1 2026 | 559,205 | $945.1K | <0.1% | +89,879+19.2% | Added | Holders |
| Q4 2025 | 469,326 | $929.3K | <0.1% | +469,326 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −16,553−100.0% | Sold out | Holders |
| Q3 2023 | 16,553 | $275.4K | <0.1% | +3,417+26.0% | Added | Holders |
| Q2 2023 | 13,136 | $322.1K | <0.1% | +13,136 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −44,400−100.0% | Sold out | Holders |
| Q1 2022 | 44,400 | $1.65M | <0.1% | +44,400 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −49,269−100.0% | Sold out | Holders |
| Q3 2021 | 49,269 | $3.06M | <0.1% | −10,721−17.9% | Reduced | Holders |
| Q2 2021 | 59,990 | $5.13M | <0.1% | +59,990 | New | Holders |